Final Agenda
E I G H T H A N N UA L
Strategic
I N AU G U R A L
Biopharma
Licensing
Alliance
Management
CONGRESS
CONGRESS
WHERE BUSINESS MEETS SCIENCE:
P E R S P E C T I V E S & D E B AT E
C O L L A B O R AT I O N S & I M P L E M E N TAT I O N
FO R S U C C E S S
April 5-6, 2011
Crowne Plaza
Philadelphia Downtown
April 6-7, 2011
Crowne Plaza
Philadelphia Downtown
Every Successful Venture Needs a Partner
>> Event Features:
Register by
January 14
and Save up to
$600!
Pre-Conference Web Symposium
February 16, 2011
• Network with 125+ Attendees
and Hear 20+ Presentations
• Choose from Multiple
Pre-Conference Workshops
and Web Symposium
• Connect with Attendees
Using CHI’s Free Intro-Net
Partnering Service
• View Novel Solutions and
Services in the Exhibit Area
• And Much More!
Strategic Alliance Business Plans: Best Practice
Examples and Templates to Help Life Science
Partners Improve Ways of Working
Pre-Conference Workshops
April 4, 2011
Workshop 1: Mergers and Acquisitions
Workshop 2: Project Management
Premier Sponsor:
Organized by:
Cambridge Healthtech Institute
Corporate Support Sponsors:
>> Presentations from:
Abbott
Bayer Healthcare Pharmaceuticals
Cornell University
Daiichi Sankyo Group
Emergent BioSolutions
Eurand
Hydra Biosciences, Inc.
MassBiologics
Micromet, Inc.
National Institutes of Health
Norgine
Novartis
Nycomed
Oregon Health & Science University
Partners Healthcare System
Ranbaxy
Santarus, Inc.
sanofi-aventis
Vantage Partners
and more!
healthtech.com/ams-lic
Schedule at a Glance
Dear Colleague,
CHI’s successful Strategic Alliance Management Congress continues
to grow! Our growth mirrors recent survey results collected from
many thought leaders in alliance management, diagnostics, medical
devices, and licensing. During the next 9-12 months, all expect to
increase their external alliances and collaborations to support their
organization’s growth activity.
The Inaugural BioPharma Licensing Congress and the 8th Annual
Strategic Alliance Management Congress provide the tools and
information to help you achieve your organizational strategy. Both
programs will feature a blend of panel discussions, case study
presentations, keynotes, two pre-conference hands-on workshops,
and small breakout discussion groups. Industry thought leaders will
discuss and debate problem-specific topics framed around:
• Life Sciences Industry
Trends & Deal
Making Strategies
• Negotiations
• Alliance Management
Lifecycle Strategies
• Performance Metrics
• Effective Communication
Management
• Organization Strategy/
Innovation
• Partner Prospects
• Scouting Innovation/
Evaluation
• Finance
• Contracts
• Due Diligence
• Execution
Wednesday Feb 16
Pre-Conference Web Symposium*
Monday PM April 4
Pre-Conference Workshops 1 & 2*
Tuesday AM April 5
Tuesday PM April 5
BioPharma Licensing Congress
BioPharma Licensing Congress
Wednesday AM April 6
Wednesday PM April 6
BioPharma Licensing Congress
Strategic Alliance Management Congress
Thursday AM April 7
Thursday PM April 7
Strategic Alliance Management Congress
Strategic Alliance Management Congress
Attendee Profile
Organization
Title
Department
Pharma
Biotech
Medical Device
Diagnostics
Solution/Service
Providers
Director/Global
Director/Associate
Director
Assistant Director
Senior Vice President
Senior Associate
Head Group Leader Lead Manager Alliance Management
Business/Corporate
Development
Licensing
Legal & Contracts
Technology Transfer
R&D
Innovation
Licensing Partnerships &
Commercial Development
Tech Licensing
Corporate New Ventures
Portfolio
Commercial Operations
Academia,
University Medical
Sciences
Associate
Officer
Director
Technology Transfer
Life Science Licensing
Research & Innovation
Office of Technology
Management
Hospitals Director/Associate
Director
Strategic Alliances or
Strategic Transactions
Speakers will be represented by a combination of organizations
including biotech, pharma, medical device, diagnostics,
therapeutics, university medical sciences, payors, solution/service
providers, attorneys, and investors.
Attendees will include approximately 150 directors/senior VPs/
managers in alliance management, licensing, technology transfer,
and R&D from pharma, biotech, medical device, diagnostics,
academia/university medical sciences, and hospitals.
Each Program is not a training course, but rather an interactive
forum where you can learn multiple viewpoints to your most
pressing questions. There are ample opportunities for all
participants to debate, interact, and network. Learn about winning deals your company should consider and
avoid; technologies in vogue now; what partners are looking
for; how not to sabotage the deal; how to demonstrate ROI &
reward; how to prove the value of alliance management to senior
management; effective communication management; models &
templates that illustrate business practices; available tools; lessons
learned, and more!
For more details and updates on both programs,
visit healthtech.com/ams-lic.
Strategic Venture Group
Research Venture &
Licensing
Pre-Conference Web
Symposium
Pre-Conference
Workshops
February 16, 2011
April 4, 2011
(*separate registration required)
Strategic Alliance Business Plans:
Best Practice Examples and
Templates to Help Life Science
Partners Improve Ways of Working
(11:30am-1:00pm)
Lead Sponsoring Publications
Web Partners
TM
2
healthtech.com/ams-lic
(*separate registration required)
Workshop 1: Mergers and
Acquisitions (1:00-3:00pm)
Workshop 2: Project
Management (3:30-5:30pm)
»»Pre-Conference Web Symposium*
»»Pre-Conference Workshops*
Strategic Alliance Business Plans: Best Practice Examples and
Templates to Help Life Science Partners Improve Ways of Working
Instructors:
Kimberly Brue, Director, Alliance Management, Prospective &
Strategic Initiatives, sanofi-aventis
Rob Hockney, Ph.D., CEO, Partnering Excellence Ltd.
In light of the economy and state of industry, life science
organizations deem alliances as critical and essential to their
organization’s growth strategy. Over the next year, a majority will
grow their alliances with new partners from many organizations
including biopharma, academia, diagnostics, and medical devices.
The process an organization uses to manage alliance activity with
each partner can be cumbersome especially if the alliance business
plan or scorecard is overly complex. How do you know what type
of plan or scorecard is effective for you and your partners to use to
ensure that all of your alliance milestones are being met and your
day-to-day work focuses on the real business priorities? While there
is no ‘one size fits all’ template, several instructors will present
several best practice examples you can glean ideas from to create a
simple, effective tool for your organization.
Workshop 1: Mergers and Acquisitions
1:00-3:00pm
Many life sciences companies are likely to execute an acquisition
in the next 12–24 months as economic conditions improve (Ernst
& Young Why Capital Matters survey, 2009). Many of you who
responded to CHI’s 2010 global alliance management survey
expressed concern about how your role would be impact if
your company were to undergo a merger and acquisition. This
workshop will explore the alliance management role in mergers
and acquisitions, best practice examples to learn from, finding
complementary companies, approaches/techniques on due
diligence, benchmarking, and smooth integration. February 16, 2011 | 11:30am-1:00pm
Monday, April 4, 2011
Workshop 2: Project Management: Keys to
Driving Successful Alliances
3:30-5:30pm
Erik J. Brenner, MBA, PMP, Senior Project Manager,
Biologics Clinical Pharmacology, Centocor R&D, a
division of J&J PRD LLC
Project management continues to be a key strategy in
helping alliances stay on track and has been employed in
rescuing others from the brink of collapse. While many
of you who responded to CHI’s 2010 global alliance management
survey expressed your understanding of this concept, you also
expressed concern about not knowing how to best use project
management to drive high performing alliances. We will explore this
issue and ways to effectively integrate project management and
alliance management. The workshop will include discussions on
leading virtual teams, achieving results with limited/shared authority,
as well as, highlight tools, best practice examples and key learnings
from alliance projects.
*separate registration required
Learning Objectives:
• Determine the type of business plan /tool needed to manage your
alliance activity
• How to use this tool internally in annual planning and externally
with strategic partners and account managers
• How to ensure alliance milestones and corporate objectives are met
Who Should Attend: Directors, group leaders, and managers in alliance
management, business development, and licensing partnerships from
biotech, pharma, medical device, and diagnostics companies. *separate registration required
April 5-6, 2011
Industry Trends
Tuesday, April 5, 2011
7:30 am Registration and Morning Coffee
8:15
8:30
Panel Discussion: Capitalizing on Global Life
Sciences Industry Trends and Deal Making Strategies
Chairperson’s Remarks
Tibor Papp M.D., Ph.D., MBA, Head of Corporate Advisory,
PharmaVentures Ltd. (Moderator)
Donna M. Shaw, Ph.D., CLP, Assistant Director, Life
Science Licensing, UC San Diego Technology Transfer
Office
Robert Bagdorf, M.D., MBA, Vice President, Worldwide Business
Development, Pfizer, Inc.
Michael D. Step, Senior Vice President, Corporate Development,
Santarus, Inc.
Frances Toneguzzo, Ph.D., Executive Director, Research
Ventures & Licensing Division, Partners Healthcare
System
Thought leaders will discuss opportunities that are in
vogue now and ones coming up in the new deal making
landscape. Where are the new technologies in POC
diagnostics, therapeutics? What are pharma, biotech, and medical
device looking for? What is venture capital trying to organize? How
3
healthtech.com/ams-lic
to strategic alliances that are beyond the traditional licensing and
sponsored programs route.
can research organizations make their technology more attractive?
Thought leaders and attendees explore how organizations can find
ways to navigate these trends to position themselves for success.
12:15 pm Luncheon Presentation (Sponsorship
Opportunity Available)
9:45
Case Study Presentation: Emerging
Partners for Emerging Markets - Utilizing a Regional
Biopharmaceutical Licensing Strategy
Scouting Innovation, Evaluation
and Due Diligence
Steven Ferguson, MBA, CLP, Deputy Director, Licensing &
Entrepreneurship, Office of Technology Transfer, National
Institutes of Health
With the rise of biopharmaceutical institutions in countries
such as China, India and other areas of the world, it is
becoming increasingly apparent that it is no longer an
absolute requirement to rely upon a single company partner to
develop a specific biopharmaceutical product on a global basis.
Regional biopharmaceutical institutions offer an “alternative” business
development strategy for new technologies other than that of the
“one size fits all” global multi-national firms. Learn how a regional
licensing approach can work based upon the experience of the
National Institutes of Health.
10:15
1:30
Panel Discussion: Organizational Models to
Consider when Sourcing New Licensing Opportunities
Cynthia Hernit-Grant, Director, Business Development,
MassBiologics (Moderator)
Sarath Chandar, Vice President, Sales and Marketing, SPI Pharma, Inc.
Dan Mallon, MBA, Director, Business Development,
Emergent BioSolutions
Networking Coffee Break in Exhibit Area
Alan Paau, Ph.D., MBA, CLP, Vice Provost for Technology
Transfer & Economic Development, Cornell University;
Executive Director, Cornell Center for Technology
Enterprise & Commercialization; President, Cornell
Research Foundation, Inc.
Organization Strategy/Innovation
10:45
Panel Discussion: Does the Industry’s
Restructuring Impact Your Organization’s Strategic Plan?
John Rothman, Ph.D., Executive Vice President, Science &
Operations, Advaxis, Inc.
If you’re a big pharma company, what do you need
from biotech and vice versa? What do you need from
diagnostics, medical device? If you’re a large company,
how do you handle inquiries and organize them en masse?
How do you pick your partner? What due diligence do you need to
have? Can the value model be straight forward? How do you convince
companies to take the risk? How do you optimize for licensing?
Thought leaders and attendees will explore these questions as well
as the values of licenses and their differences between businesses
(medical industry versus food industry).
Timothy Herpin, Ph.D., Director, Strategic Transactions
Group, Bristol-Myers Squibb (Moderator)
Andy Brookes, Divisional Vice President, Intellectual
Property Strategy, Pharmaceutical Products Group, Abbott
Don Urbanowicz, Principal, Urbanowicz Consulting, LLC;
formerly Vice President, Business Development, Stryker
Orthopedics
2:30
Case Study Presentation: Grow Your Biosimilars
Business through Licensing, Partnerships, and Acquisitions
Shyam Bishen, Ph.D., MBA, Vice President, Corporate
Development, Ranbaxy
Biosimilars is a fast emerging field. This presentation
will highlight the current biosimilars landscape and how
companies are utilizing acquisitions to enter this lucrative
field. A survey of various licensing & partnership deals for
development and marketing of biosimilars will be presented. Ranbaxy’s
entry into biosimilars and vaccine space through acquisitions and
partnership will be highlighted as a case example.
Jeffrey Warmke, Ph.D., Senior Vice President, External
Scientific Affairs, Daiichi Sankyo Group
Should companies hold onto research function, sales force?
Where will funding of various pieces come from and what
will big pharma be interested in keeping for product? Can
we expect same returns from investment as previously
seen or are the margins smaller? Should collaborations start at an early
stage? Thought leaders and attendees will explore these questions as
well as how the industry’s restructuring may impact you in developing
and licensing technology/products.
3:00
Networking Refreshment Break in Exhibit Area
3:30
Interactive Small Discussion Groups and
Report Outs
These concurrent discussion groups provide you a chance to delve deeper
into some of the questions that were raised in the kick-off session and
concepts that were raised in the subsequent talks. Each discussion group
will be limited to twelve (12) participants and a facilitator.
11:45
Case Study Presentation: A New Paradigm for
Academic - Corporate Partnering
Abhijit Banerjee, Ph.D., MBA, Director, Business
Development, Technology Transfer & Business
Development, Oregon Health & Science University
Academic Institutes are partnering with just not only
pharmaceutical and biotech companies. They are
aggressively exploring and partnering with other academic
institutes, hospitals, CROs, and VCs both in and outside the US.
This shift in academic institutes mindset has allowed organizations
to look at alliances beyond traditional licensing and sponsored
research programs. This talk will explore how these models can lead
5:00 - 6:00 Networking Cocktail Reception in Exhibit Area
(Sponsorship Opportunity Available)
4
healthtech.com/ams-lic
Wednesday, April 6, 2011
8:30 am Chairperson’s Remarks & Recap of Previous Day
Donna M. Shaw, Ph.D., CLP, Assistant Director, Life
Science Licensing, UC San Diego Technology Transfer
Office
Finance/Contract
8:45
Panel Discussion: Licensing Deals Gone Bad and
How to Best Rectify Them
Irina Erenburg, Ph.D., Director, Strategic Transactions,
Research Ventures and Licensing Partners Healthcare
System
How do big and small companies look at contracts?
How do companies deal with expenses that weren’t
anticipated? Can signing a license be a barrier to entry?
How are milestones and royalty rates set? Should a reimbursement
risk be included in the deal structure? Is a VC financed deal better
than a pharma financed deal? How can licensing be used as a nonfunding mechanism? What do you do when you and your partner no
longer have shared objectives? Thought leaders and attendees will
explore these questions as well as criteria for not killing a deal.
9:45
Sponsored Presentation (Opportunity Available)
10:15
Networking Coffee Break in Exhibit Area
Execution & Communication
10:45
Panel Discussion: Tell Us What You Don’t Like
About Your Partnership
Ailsa Mendez-Fitzwilliam, Director, Project Governance, Functional
Genetics (Moderator)
Anne Altmeyer, Ph.D., MBA, MPH, Executive Director,
Business Development & Licensing, Oncology, Novartis
Pharmaceuticals Corporation
Bethany J. Mancilla, Vice President, Business Development & Alliance
Management, Micromet, Inc.
Personality of deal makers and people with poor interactive skills
impact a deal’s demise or success. Thought leaders and attendees
will share best practices in deal execution and communication.
Additionally, we’ll discuss other execution situations including how
to handle small companies who want to be involved in clinical trial
design and fostering open communication to keep the deal from
falling apart.
11:45
Case Study Presentation: The Partnering
Survival Manual - Lessons Learned and Tips to Get Your
Alliance Off to a Good Start
Alessandro Foti, MBA, PMI, Head, Program Management,
Hydra Biosciences, Inc.
While the terms “alliance” and “partnership” may suggest
otherwise, parties in an alliance are usually not equal
in status, and never in nature. Starting at due diligence,
navigating towards success requires steering around
the expectations, attitudes, processes and motivations of two very
different groups, and only careful consideration of the needs, cultures
and hidden agendas of the parties involved can lead to positive results.
Observations, experience and lessons learned from a typical “alliance
of unequals,” will be shared.
12:15 pm Close of Biopharma Licensing Congress
5
healthtech.com/ams-lic
April 6-7, 2011
Wednesday, April 6, 2011
success. Through the process, Nycomed learned some significant
lessons and identified five steps to successfully develop and enhance
alliance capability. This presentation will discuss how Nycomed
developed capability, tools and processes; leveraged buy-in from
senior management and project management functions; clarified
roles and responsibilities between alliance management, business
development, project management; ensured accountability; began
tracking commitments; and effectively supported and continues to
support corporate needs with limited headcount by prioritizing efforts,
and determining alliances that require enabling vs. direct support.
12:00 pm Registration
2:00
Chairperson’s Remarks
Sponsored by
2:15
Interactive Large Group
Discussion & Report Outs
Moderator: Stuart Kliman, J.D.,
Founder and Partner, Vantage Partners
The Congress will kick-off with an interactive large group
discussion with all participants. Delve deep into some of
the key themes and concepts that appear on the agenda
- industry trends & deal making strategies, negotiations,
alliance management lifecycle strategies, performance metrics &
tools, and effective communication management - and discuss the
big questions you have on your mind. Through the course of the
session, you’ll vet ideas with peers, be part of group interrogation
and problem solving, and, most importantly, participate in active idea
sharing. We will record your questions about the themes and look to
return to those over and over throughout the entire Congress. To get
the most out of this interactive session, please come prepared to ask
questions and share problems/examples from your work. You’ll start
your Congress experience with ideas you can immediately apply back
home.
»»Featured Keynote Presentation
5:30
6:00 - 7:00 Networking Cocktail Reception in Exhibit Area
(Sponsorship Opportunity Available)
Thursday April 7, 2011
8:15 am Chairperson’s Remarks
»»Interactive Keynote Discussion
8:30
Alliance Management:
Balancing Organization Growth
through Strategy vs. Partnerships
3:15
New Trends in Creative Deal –Making in
Pharmaceuticals
Tibor Papp M.D., Ph.D., MBA, Head of Corporate
Advisory, PharmaVentures Ltd.
Business developers of pharmaceutical and biotechnology
companies have probably never faced such high demand
for their skills than in the past two years of high pipeline
and market growth pressures. Capturing the promise of
external innovation in creative risk sharing agreements has proved to
be a successful formula for generating capital efficient platforms for
growth. Competition for good technologies is very intense and those
companies with limited risk appetite have to be particularly smart in
their offered deal structures. The presentation will present new trends
and cases in creative risk sharing deal making.
3:45
Networking Refreshment Break in Exhibit Area
4:15
Sponsored Presentation (Opportunity Available)
Alliance Management Strategy and Oncology
Varavani Dwarki, Worldwide Head, Alliance Management – Oncology,
sanofi-aventis
Sponsored by
Stuart Kliman, J.D., Founder and Partner, Vantage Partners
Over the last several years more and more organizations
have implemented an alliance management function.
Those who have been successful at helping their
organizations grow through partnerships begin to grapple
with the unique challenges of executing against a strategy
that relies only on an alliance to succeed. What ties corporate
strategy, alliances, and growth together? How do organizations grow
through strategy as well as partnerships? This interactive session will
share multiple examples of efforts that life sciences organizations
are taking to enhance their alliance management capabilities. We will
facilitate a discussion about what ties these disparate efforts together
and share a few thoughts about the next steps these organizations
can take in their quest to add demonstrable value.
5:00
The Nycomed Journey: 5 Steps to
Embedding Capability
Mark Wingertzahn, Head of Alliance Management and
Senior Director of Research and Development, Nycomed
During the past two years Nycomed has gone from having
no scalable approach for managing alliances to building
an organizational capability with processes, tools, and
support systems to maximize the chance for alliance
6
healthtech.com/ams-lic
9:15
Expanding and Evolving Your Alliance
Management Approach for Global Partners
leadership and communicating the forward-looking vision; reducing
the level of “noise” that distracts the team(s) from moving forward;
communicating the boundaries of information sharing in a way that
does not lead to greater miscommunication and distrust; and, helping
the project team(s) build and/or maintain a perception of the partner
as a capable company able to drive value for your organization.
Matt Siefert, MBA, Manager, Alliance Management, U.S.
Business Development, Eurand
2:00
Norgine’s Journey: Best Practice Examples and
Tools to Support Alliance Management Growth
Daniela Sican, Alliance Manager, Commercial Operations, Eurand
With more than 40 products commercialized by partners around
the world, Eurand has succeeded in expanding their Alliance
Management team, while continually adapting their approach for
diverse, global partnerships. Eurand offers insight into a sophisticated
approach to structuring alliances and alliance success. This approach
is applicable globally regardless of partner size, territory, and other
variables specific to each partner. Case studies will be presented
illustrating the cultural and logistical challenges faced, as well as
solutions and key learnings that allow the company to continue
building successful alliances in Asian and emerging markets.
Angela Boyhan, Ph.D., Director, Evaluation & Alliance
Management, Norgine
Norgine is a rapidly growing, private, European specialty
pharmaceutical company with sales in excess of € 250
M pa. The company has multiple partnerships, covering
in-licensed and out-licensed products. The alliance
management function at Norgine was established in 2009 within the
Corporate and Business Development department. This presentation
will discuss the alliance management function and its evolution, the
role in due diligence, the partnership with business development
and product development functions, and tools and processes to
effectively manage ongoing alliances and new partnerships.
9:45
Implementing Collaborative Innovation: Lessons
from the Leaders
2:30
A Uniquely Intimate Collaboration between
Industry and Academia
Gene Slowinski, Ph.D., Director, Strategic Alliance
Research, Rutgers University Graduate School of
Management
Collaborative Innovation is transforming the nature of
technology development and commercialization. To
compete effectively in today’s business environment,
firms are using strategic alliances to link their resources with the
complementary resources of other world-class organizations. They
are replacing the “not invented here” syndrome with the “invented
anywhere approach.” Unfortunately, many alliances fail. Managers
must deal with the complexities of allocating rights to jointly
developed intellectual assets, protecting proprietary know-how and
trade secrets, linking decision-making structures and utilizing financial
models that allow both firms to share the risks as well as rewards of
collaboration. Learn a set of simple, but powerful management tools
and metrics to increase the value of both your individual alliances and
alliance portfolios.
Peter Covitz Ph.D., Senior Vice President, Innovation,
Nordion
Nordion is collaborating with the University of Ottawa
Heart Institute (UOHI), Canada’s largest cardiovascular
health centre, and has established a Molecular Imaging
Centre of Excellence to advance cardiology research.
Nordion and UOHI scientists collaborate on the development of new
cardiac imaging technologies that will be commercialized by Nordion.
In addition, Nordion provides innovative molecular imaging services to
biopharmaceutical companies to help them accelerate their biologics
development programs. This talk will present the lessons learned
from this collaboration and will describe how co-location of Nordion
assets on site at the University has enabled leveraging of University
faculty, staff and other resources.
3:00
Networking Refreshment Break in Exhibit Area
10:15
3:30
Sponsored Presentation (Opportunity Available)
Networking Coffee Break in Exhibit Area
10:45
Interactive Small Discussion Groups and
Report Outs
These concurrent discussion groups provide you a chance to delve
deeper into some of the questions that were raised in the kick-off
session and concepts that were raised in the subsequent talks.
Each discussion group will be limited to twelve (12) participants and
a facilitator.
12:15 pm Luncheon Presentation (Sponsorship
Opportunity Available)
1:30
Working In and Managing an Alliance
under Litigation
Laura Pierce, Vice President and Head of Alliance
Management, Bayer Schering Pharma
In today’s business environment, just because you have
initiated legal proceedings against your partner (or they
have against you) the alliance does not stop. Even under
the cloud of litigation, alliance partners can – and often
should – continue to work toward common goals and generate
significant value for themselves and each other. Doing so, however, is
tricky. This talk will share experiences and advice regarding: engaging
7
healthtech.com/ams-lic
4:00
Panel Discussion with
Alliance Management Leaders:
The Future of Alliance Management
Sponsored by
The Congress ends with an interactive panel discussion with several
heads of alliance management. They will share their thoughts and
perspectives on the issues unveiled during the large group breakout
discussion on Day 1 and themes covered throughout the Congress
- industry trends & deal making strategies, negotiations, alliance
management lifecycle strategies, performance metrics, and effective
communication management.
Moderator:
Stuart Kliman, J.D., Founder and Partner, Vantage Partners
Panelists:
Laura Pierce, Vice President, Alliance Management, Bayer
Healthcare Pharmaceuticals
Donna Taneja, Ph.D., Senior Director, Alliance Management, Daiichi
Sankyo Group
Mark Wingertzahn, Head of Alliance Management and
Senior Director of Research and Development, Nycomed
5:00
Close of Strategic Alliance Management Congress
Take Advantage of One-to-One Meetings
Using CHI’s Intro-Net
CHI’s Intro-Net offers you the opportunity to set up meetings
throughout the two days with selected attendees before, during
and after the conference, allowing you to connect to the key
people that you want to meet. This online system was designed
with your privacy in mind and is only available to registered
session attendees of this event.
Alliance
MANAGEMENT &
Business
DEVELOPMENT
Network
NETWORK
Alliance Management and Business Development
NetworkNETWORK
on LinkedIn
Stay connected on the latest Industry news! Join Alliance
Management on LinkedIn - 1,000+ members strong and growing.
NETWORK
8
healthtech.com/ams-lic
Hotel & Travel Information
Conference Hotel:
Crowne Plaza Philadelphia Downtown
1800 Market Street
Philadelphia, PA 19103
T: 215-561-7500
Room Rate: $159 s/d
Reservation Cut-off: March 4, 2011
Please visit our conference website to make your
reservations online or call the hotel directly to reserve
your sleeping accommodations. Identify yourself as a
Cambridge Healthtech Institute conference attendee
to receive the reduced room rate. Reservations
made after the cut-off date or after the group room
block has been filled (whichever comes first) will
be accepted on a space-and-rate-availability basis.
Rooms are limited, so please book early.
Flight Discounts:
To receive a 5% or greater discount on all American
Airline flights, please use one of the following
methods:
• Call 1-800-433-1790 (use Conference code
8941AV).
• Go online at www.aa.com (enter Conference code
8941AV in Promotion discount box).
• Contact Wendy Levine, ProTravel/Great
International Travel, 1-800-336-5248 ext. 3737
Car Rental Discounts:
Special discount rentals have been established with
Hertz for this conference. Please use one of the
following methods:
• Call HERTZ, 800-654-3131 use our Hertz
Convention Number (CV): 04KL0002
• Go online www.hertz.com use our Hertz
Convention Number (CV): 04KL0002 in
Promotion discount box.
ABOUT OUR PREMIER SPONSOR
helps the world’s leading companies to effectively
negotiate, build and manage their most critical relationships. A spin-off
of the Harvard Negotiation Project, Vantage brings over twenty years
of research and hands on experience consulting to Alliance, Sales, and
Sourcing & Procurement groups in various industries throughout the
world. Vantage-authored publications include bestselling management
books such as Measuring the Value of Partnering, Getting to Yes and
Difficult Conversations, along with articles in management periodicals
such as the Harvard Business Review and Sloan Management Review.
Cambridge Healthtech Institute (CHI) is the preeminent life
science network for leading researchers and business experts from top
pharmaceutical, biotech and academic organizations. Founded in 1992,
Cambridge Healthtech Institute strives to develop quality information
sources that provide valuable new insights and competing points of
view while offering balanced coverage of the latest developments. Basic
research related to commercial implications is covered, with heavy
emphasis placed on end-user insights into new products and technology
as well as coverage on the strategy behind the business.
www.chicorporate.com
BECOME A SPONSOR
Your company has a unique opportunity to influence this major gathering
of key pharma and biotech executives. Brand your company as a
thought leader by participating as an active sponsor. Presenting your
solutions or services directly to our top-tier delegates can significantly
impact their purchasing and collaboration decisions and help you achieve
your sales and business development objectives.
Presentation opportunities include agenda presentations, breakfast and
luncheon presentations, or you may pre-select and gain access to your
highest-level prospects through an Invitation-Only VIP Dinner or function
(limited availability). CHI will support your sponsorship and brand your
company with strong marketing programs before, during and after the
event. The earlier you secure your sponsorship, the more opportunity
for exposure.
For more information, or to contract your sponsorship or exhibit
space today, please contact:
Joseph Vacca
Manager, Business Development
BioPharma Strategy Series (BSS)
Phone: 781-972-5431
Mobile: 781-697-9400
Email: [email protected]
9
healthtech.com/ams-lic
How to Register
E I G H T H A N N UA L
Strategic
healthtech.com/ams-lic
P: 781.972.5400 or Toll-free in
the U.S. 888.999.6288
Alliance
Management
CONGRESS
April 6-7, 2011
E: [email protected]
I N AU G U R A L
Biopharma
Licensing
CONGRESS
April 5-6, 2011
Crowne Plaza Philadelphia Downtown
Pricing and Registration Information
Key Code AMS F
PRE-CONFRENCE PRICING
Web Symposium (February 16) $595 Individual
$1495 Group (over 3)
Workshops (April 4) $695 Single Workshop $895 Two Workshops
Workshop 1 (1:00-3:00)
Workshop 2 (3:30-5:30)
Mergers & Acquisitions
Project Management
Package pricing Best Value!
Includes access to 2 conferences, Academic, Government,
BioPharma Licensing Congress (April 5-6)
CommercialHospital-affiliated
and Alliance Management Congress (April 6-7)
Early Registration Deadline until January 14, 2011
$2795
$1395
Advance Registration Deadline until February 25, 2011
$2995
$1495
Registrations after February 25, 2011 and on-site
$3395 $1695
Individual Conference Pricing
Academic, Government,
CommercialHospital-affiliated
Early Registration Deadline until January 14, 2011
$1895
$945
Advance Registration Deadline until February 25, 2011
$1995
$995
Registrations after February 25, 2011 and on-site
$2295 $1145
April 5-6
April 6-7
BioPharma Licensing Congress
Alliance Management Congress
Additional registration details
Each registration includes all conference
sessions, posters and exhibits, food
functions, and a copy of the conference
proceedings link.
Handicapped Equal Access: In accordance
with the ADA, Cambridge Healthtech
Institute is pleased to arrange special
accommodations for attendees with
special needs. All requests for such
assistance must be submitted in writing
to CHI at least 30 days prior to the start
of the meeting.
To view our Substitutions/
Cancellations Policy, go to
http://www.healthtech.com/regdetails
NOTE: Cancellations will only be
accepted up to two weeks prior to the
conference. Program and speakers are
subject to change. Video and or audio
recording of any kind is prohibited onsite
at all CHI events.
Cd’s
If you cannot attend, you can still
purchase the Strategic Alliance
Management Congress CD at
healthtech.com/ams and/or
Biopharma Licensing Congress CD at
healthtech.com/lic for $350 each
(plus shipping). Massachusetts delivery
will include sales tax.
CONFERENCE DISCOUNTS
REGISTER 3 ­- 4th IS FREE: Individuals must register for the same conference or conference combination and submit completed registration form
together for discount to apply. Please reproduce this registration form as needed.
GROUP DISCOUNTS AVAILABLE! Special rates are available for multiple attendees from the same organization.
For more information on group discounts contact David Cunningham at +1-781-972-5472
Please refer to the Registration Code below:
Cambridge Healthtech Institute
250 First Avenue, Suite 300, Needham, Massachusetts 02494
T: 781-972-5400 or toll-free in the U.S. 888-999-6288
F: 781-972-5425 • www.healthtech.com